The U.S. Defense Health Agency (DHA) awarded a $127,040.00 firm fixed-price purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for 12 months of service and maintenance. The contract has no set-aside designation. Cepheid, a subsidiary of Danaher Corporation, has been awarded numerous prime federal contracts to provide diagnostic testing equipment, reagents, consumables, and associated maintenance and support services to various agencies, including the...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $123,607.98, is for a service agreement (GX16A1Y) with an ultimate completion date of April 12, 2027. Cepheid, which is registered in the System for Award Management (SAM.gov), will provide the DHA with GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to...
The Defense Health Agency has awarded a firm-fixed-price purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a GeneXpert IV Service Agreement plus four option years. The contract, valued at $36,197.21, will provide GeneXpert diagnostic equipment, reagents, consumables, and maintenance services to support clinical testing programs for the agency. Cepheid is the prime contractor and original equipment manufacturer, and the contract does not have a...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions including infectious disease and genetic tests. The $36,915.00 contract is for a 5-year warranty and maintenance service on Cepheid's diagnostic equipment. There is no set-aside designation. Cepheid has received numerous other federal contracts and subcontracts to provide diagnostic testing products and support services to agencies such...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for $13,000.50 to provide maintenance service for GeneXpert diagnostic equipment. The contract has an ultimate completion date of April 17, 2025. Cepheid is a leading provider of diagnostic equipment, reagents, and support services to federal agencies, including the Department of Veterans Affairs (VA) and Department of Health and Human...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide annual maintenance services for GeneXpert diagnostic systems. The $161,500.00 contract has a completion date of August 28, 2027 and does not have a set-aside designation. Cepheid has received numerous other federal contract awards and grants to supply the Department of Veterans Affairs, the Defense Logistics Agency, and the...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a Laboratory Cepheid GeneXpert Service Agreement. The $103,975.00 contract has a period of performance through June 18, 2028 and does not have a set-aside designation. Cepheid has received numerous prime federal contracts to provide diagnostic testing equipment, reagents, consumables, and associated maintenance and support services to...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract provides for annual preventive maintenance services with a total potential value of $215,902 and a period of performance through June 30, 2027. The contract does not have a set-aside designation. Cepheid is an experienced federal contractor, having previously been awarded numerous prime contracts and...
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the provision of test kits for Cepheid's GeneXpert DX instruments. These instruments are utilized to perform rapid testing for infectious diseases. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price, has a ceiling value of $249,368.13, and an ultimate completion date of May 14, 2025. The award was made by the Defense Health Agency (DHA), a defense agency, on...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $199,744.50, is for a standard service agreement for Cepheid's GeneXpert system. The contract has an ultimate completion date of December 10, 2026. Cepheid is the prime contractor and there is no set-aside designation for this award. Cepheid has previously received numerous federal contract and grant awards from agencies...